Display options
Share it on

Chem Commun (Camb). 2019 Dec 28;55(100):15121-15124. doi: 10.1039/c9cc07803g. Epub 2019 Nov 29.

Selective modification of a native protein in a patient tissue homogenate using palladium nanoparticles.

Chemical communications (Cambridge, England)

Arnaud Peramo, Anaëlle Dumas, Hynd Remita, Mireille Benoît, Stephanie Yen-Nicolay, Raphaël Corre, Ruy A Louzada, Corinne Dupuy, Shannon Pecnard, Benoit Lambert, Jacques Young, Didier Desmaële, Patrick Couvreur

Affiliations

  1. Institut Galien Paris-Sud, UMR 8612, CNRS Univ. Paris-Sud, Université Paris-Saclay, Faculté de Pharmacie 5 rue Jean-Baptiste Clément, 92290 Chatenay-Malabry, France. [email protected].
  2. Laboratoire de Chimie Physique, UMR 8000-CNRS, Bâtiment 349, Université Paris-Sud, Université Paris-Saclay, Rue Michel Magat, 91400 Orsay, 91405 Orsay, France.
  3. Trans-Prot, UMS IPSIT, Univ. Paris-Sud, Université Paris-Saclay, Faculté de Pharmacie 5 rue JB Clément, 92296 Châtenay-Malabry, France.
  4. Institut de Cancérologie Gustave Roussy, UMR8200 CNRS, 114 rue Edouard Vaillant, 94805 Villejuif, France.
  5. Hôpital Bicêtre, 78 rue du Général Leclerc, 94270 Le Kremlin-Bicêtre, France.

PMID: 31782421 DOI: 10.1039/c9cc07803g

Abstract

We have developed new benign palladium nanoparticles able to catalyze the Suzuki-Miyaura cross-coupling reaction on human thyroglobulin (Tg), a naturally iodinated protein produced by the thyroid gland, in homogenates from patients' tissues. This represents the first example of a chemoselective native protein modification using transition metal nanoobjects in near-organ medium.

Publication Types